Paul Thielking
Chief Tech/Sci/R&D Officer chez NUMINUS WELLNESS INC.
Fortune : - $ au 31/03/2024
Profil
Paul Thielking is currently the Chief Science Officer at Numinus Wellness, Inc. Prior to this, he worked as the Director of Psycho Oncology at Huntsman Cancer Institute, an Associate Professor at the University of Utah, and the Chief Scientific Officer at Novamind, Inc.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
NUMINUS WELLNESS INC
-.--% | 01/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Paul Thielking
Sociétés | Poste | Début |
---|---|---|
NUMINUS WELLNESS INC. | Chief Tech/Sci/R&D Officer | 10/06/2022 |
Anciens postes connus de Paul Thielking
Sociétés | Poste | Fin |
---|---|---|
Huntsman Cancer Institute | Corporate Officer/Principal | - |
University of Utah | Corporate Officer/Principal | - |
NOVAMIND INC. | Chief Tech/Sci/R&D Officer | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
NUMINUS WELLNESS INC. | Health Services |
Entreprise privées | 2 |
---|---|
Novamind, Inc.
Novamind, Inc. Medical/Nursing ServicesHealth Services Novamind, Inc. is a mental health company, which engages in enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. It offers outpatient mental health services, and provides clinical trial services through its subsidiary. It operates through the Cedar Psychiatry and Cedar Clinical Research business divisions. The company was founded by Yaron Conforti, Jesse Kaplan, and Sruli Weinreb on April 23, 1997 and is headquartered in Toronto, Canada. | Health Services |
Huntsman Cancer Institute |